Ubs Asset Management Americas Inc Sarepta Therapeutics, Inc. Transaction History

Ubs Asset Management Americas Inc

$277 Billion
Q1 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 161,027 shares of SRPT stock, worth $24.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

161,027

Previous 161,012 0.01%

Holding current value

$24.7 Million

Previous $15.5 Million 34.27%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$93.7 - $141.53 $1,405 - $2,122	15 Added 0.01%	161,027 $20.8 Million
Q4 2023 Feb 14, 2024	SELL	$67.31 - $124.76 $11,442 - $21,209	-170 Reduced 0.11%	161,012 $15.5 Million
Q3 2023 Nov 13, 2023	BUY	$102.5 - $123.59 $460,532 - $555,289	4,493 Added 2.87%	161,182 $19.5 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $4.16 Million - $5.52 Million	35,368 Added 29.15%	156,689 $21.6 Million
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $126,478 - $165,691	1,254 Added 1.04%	121,321 $15.7 Million

Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $1.4 Million - $2.2 Million	-18,440 Reduced 13.31%	120,067 $13.3 Million
Q2 2022 Aug 12, 2022	BUY	$62.69 - $88.44 $60,307 - $85,079	962 Added 0.7%	138,507 $10.4 Million
Q1 2022 May 16, 2022	SELL	$63.15 - $90.42 $1.72 Million - $2.46 Million	-27,201 Reduced 16.51%	137,545 $10.7 Million
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $4.84 Million - $6.23 Million	62,655 Added 61.37%	164,746 $14.8 Million
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $635,423 - $890,767	-9,632 Reduced 8.62%	102,091 $9.44 Million
Q2 2021 Aug 16, 2021	SELL	$69.38 - $86.75 $6.47 Million - $8.1 Million	-93,319 Reduced 45.51%	111,723 $8.69 Million
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $14.6 Million - $34 Million	-201,513 Reduced 49.57%	205,042 $15.3 Million
Q4 2020 Mar 01, 2021	BUY	$125.56 - $178.74 $1.34 Million - $1.91 Million	10,676 Added 2.7%	406,555 $69.3 Million
Q3 2020 Nov 13, 2020	BUY	$127.12 - $172.34 $43,220 - $58,595	340 Added 0.09%	395,879 $55.6 Million
Q2 2020 Aug 14, 2020	SELL	$93.0 - $171.7 $5.61 Million - $10.4 Million	-60,320 Reduced 13.23%	395,539 $63.4 Million
Q1 2020 May 15, 2020	BUY	$82.38 - $131.64 $361,318 - $577,373	4,386 Added 0.97%	455,859 $44.6 Million
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $4.47 Million - $7.91 Million	58,372 Added 14.85%	451,473 $58.3 Million
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $7.03 Million - $15.1 Million	96,536 Added 32.55%	393,101 $29.6 Million
Q2 2019 Aug 15, 2019	BUY	$112.21 - $151.95 $4.74 Million - $6.42 Million	42,263 Added 16.62%	296,565 $0
Q1 2019 May 14, 2019	BUY	$106.67 - $151.68 $1.06 Million - $1.5 Million	9,919 Added 4.06%	254,302 $0
Q4 2018 Feb 13, 2019	BUY	$97.32 - $148.76 $2.07 Million - $3.16 Million	21,262 Added 9.53%	244,383 $26.7 Million
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $25.7 Million - $36 Million	223,121 New	223,121 $0

Others Institutions Holding SRPT

# of Institutions

470

Shares Held

79.3M

Call Options Held

4.23M

Put Options Held

1.21M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $13.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Sarepta Therapeutics, Inc. Transaction History